 | • レポートコード：MRC2-11QY04623 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は副鼻腔炎薬のグローバル市場について調査・分析したレポートです。種類別（鎮痛剤、抗ヒスタミン剤、コルチコステロイド、抗生物質、スルホンアミド）市場規模、用途別（急性副鼻腔炎、慢性副鼻腔炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別副鼻腔炎薬の競争状況、市場シェア ・世界の副鼻腔炎薬市場：種類別市場規模 2015年-2020年（鎮痛剤、抗ヒスタミン剤、コルチコステロイド、抗生物質、スルホンアミド） ・世界の副鼻腔炎薬市場：種類別市場規模予測 2021年-2026年（鎮痛剤、抗ヒスタミン剤、コルチコステロイド、抗生物質、スルホンアミド） ・世界の副鼻腔炎薬市場：用途別市場規模 2015年-2020年（急性副鼻腔炎、慢性副鼻腔炎） ・世界の副鼻腔炎薬市場：用途別市場規模予測 2021年-2026年（急性副鼻腔炎、慢性副鼻腔炎） ・北米の副鼻腔炎薬市場分析：米国、カナダ ・ヨーロッパの副鼻腔炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの副鼻腔炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の副鼻腔炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの副鼻腔炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Bayer、Pfizer、AstraZeneca、Novartis、Johnson & Johnson、Merck、Amgen、Teva Pharmaceutical、Fresenius Kabi、Bionorica、Dr. Reddy's Laboratories、Sun Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The sinuses are a connected system of air-filled cavities located in the skull. Sinusitis is an inflammation of the sinus lining caused by bacteria, viruses, fungi, and microbes.
Increase in upper respiratory tract infections and rise in incidence of chronic rhinosinusitis (CRS) across the world are projected to drive the global sinusitis drugs market during the forecast period. Additionally, technological advancements in diagnostic procedures and demand for antibiotic are anticipated to propel the global sinusitis drugs market in the near future. However, high cost of diagnostic tests and side effects of corticosteroids are likely to restrain the global drugs market.
Market Analysis and Insights: Global Sinusitis Drugs Market
The global Sinusitis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sinusitis Drugs Scope and Market Size
Sinusitis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sinusitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Bayer
Pfizer
AstraZeneca
Novartis
Johnson & Johnson
Merck
Amgen
Teva Pharmaceutical
Fresenius Kabi
Bionorica
Dr. Reddy’s Laboratories
Sun Pharmaceutical
Market segment by Type, the product can be split into
Analgesics
Antihistamines
Corticosteroids
Antibiotics
Sulphonamides
Market segment by Application, split into
Acute Sinusitis
Chronic Sinusitis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sinusitis Drugs Revenue
1.4 Market by Type
1.4.1 Global Sinusitis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Analgesics
1.4.3 Antihistamines
1.4.4 Corticosteroids
1.4.5 Antibiotics
1.4.6 Sulphonamides
1.5 Market by Application
1.5.1 Global Sinusitis Drugs Market Share by Application: 2020 VS 2026
1.5.2 Acute Sinusitis
1.5.3 Chronic Sinusitis
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sinusitis Drugs Market Perspective (2015-2026)
2.2 Global Sinusitis Drugs Growth Trends by Regions
2.2.1 Sinusitis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sinusitis Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Sinusitis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sinusitis Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Sinusitis Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sinusitis Drugs Players by Market Size
3.1.1 Global Top Sinusitis Drugs Players by Revenue (2015-2020)
3.1.2 Global Sinusitis Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Sinusitis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sinusitis Drugs Market Concentration Ratio
3.2.1 Global Sinusitis Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sinusitis Drugs Revenue in 2019
3.3 Sinusitis Drugs Key Players Head office and Area Served
3.4 Key Players Sinusitis Drugs Product Solution and Service
3.5 Date of Enter into Sinusitis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sinusitis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Sinusitis Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sinusitis Drugs Market Size by Application (2015-2020)
5.2 Global Sinusitis Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sinusitis Drugs Market Size (2015-2020)
6.2 Sinusitis Drugs Key Players in North America (2019-2020)
6.3 North America Sinusitis Drugs Market Size by Type (2015-2020)
6.4 North America Sinusitis Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sinusitis Drugs Market Size (2015-2020)
7.2 Sinusitis Drugs Key Players in Europe (2019-2020)
7.3 Europe Sinusitis Drugs Market Size by Type (2015-2020)
7.4 Europe Sinusitis Drugs Market Size by Application (2015-2020)
8 China
8.1 China Sinusitis Drugs Market Size (2015-2020)
8.2 Sinusitis Drugs Key Players in China (2019-2020)
8.3 China Sinusitis Drugs Market Size by Type (2015-2020)
8.4 China Sinusitis Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sinusitis Drugs Market Size (2015-2020)
9.2 Sinusitis Drugs Key Players in Japan (2019-2020)
9.3 Japan Sinusitis Drugs Market Size by Type (2015-2020)
9.4 Japan Sinusitis Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sinusitis Drugs Market Size (2015-2020)
10.2 Sinusitis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sinusitis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Sinusitis Drugs Market Size by Application (2015-2020)
11 India
11.1 India Sinusitis Drugs Market Size (2015-2020)
11.2 Sinusitis Drugs Key Players in India (2019-2020)
11.3 India Sinusitis Drugs Market Size by Type (2015-2020)
11.4 India Sinusitis Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sinusitis Drugs Market Size (2015-2020)
12.2 Sinusitis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Sinusitis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Sinusitis Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Sinusitis Drugs Introduction
13.1.4 Sanofi Revenue in Sinusitis Drugs Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Sinusitis Drugs Introduction
13.2.4 Bayer Revenue in Sinusitis Drugs Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Sinusitis Drugs Introduction
13.3.4 Pfizer Revenue in Sinusitis Drugs Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Sinusitis Drugs Introduction
13.4.4 AstraZeneca Revenue in Sinusitis Drugs Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Sinusitis Drugs Introduction
13.5.4 Novartis Revenue in Sinusitis Drugs Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Sinusitis Drugs Introduction
13.6.4 Johnson & Johnson Revenue in Sinusitis Drugs Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Sinusitis Drugs Introduction
13.7.4 Merck Revenue in Sinusitis Drugs Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview
13.8.3 Amgen Sinusitis Drugs Introduction
13.8.4 Amgen Revenue in Sinusitis Drugs Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Details
13.9.2 Teva Pharmaceutical Business Overview
13.9.3 Teva Pharmaceutical Sinusitis Drugs Introduction
13.9.4 Teva Pharmaceutical Revenue in Sinusitis Drugs Business (2015-2020)
13.9.5 Teva Pharmaceutical Recent Development
13.10 Fresenius Kabi
13.10.1 Fresenius Kabi Company Details
13.10.2 Fresenius Kabi Business Overview
13.10.3 Fresenius Kabi Sinusitis Drugs Introduction
13.10.4 Fresenius Kabi Revenue in Sinusitis Drugs Business (2015-2020)
13.10.5 Fresenius Kabi Recent Development
13.11 Bionorica
10.11.1 Bionorica Company Details
10.11.2 Bionorica Business Overview
10.11.3 Bionorica Sinusitis Drugs Introduction
10.11.4 Bionorica Revenue in Sinusitis Drugs Business (2015-2020)
10.11.5 Bionorica Recent Development
13.12 Dr. Reddy’s Laboratories
10.12.1 Dr. Reddy’s Laboratories Company Details
10.12.2 Dr. Reddy’s Laboratories Business Overview
10.12.3 Dr. Reddy’s Laboratories Sinusitis Drugs Introduction
10.12.4 Dr. Reddy’s Laboratories Revenue in Sinusitis Drugs Business (2015-2020)
10.12.5 Dr. Reddy’s Laboratories Recent Development
13.13 Sun Pharmaceutical
10.13.1 Sun Pharmaceutical Company Details
10.13.2 Sun Pharmaceutical Business Overview
10.13.3 Sun Pharmaceutical Sinusitis Drugs Introduction
10.13.4 Sun Pharmaceutical Revenue in Sinusitis Drugs Business (2015-2020)
10.13.5 Sun Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Sinusitis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Sinusitis Drugs Revenue
Table 3. Ranking of Global Top Sinusitis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sinusitis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analgesics
Table 6. Key Players of Antihistamines
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Antibiotics
Table 9. Key Players of Sulphonamides
Table 10. Global Sinusitis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Sinusitis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Sinusitis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Sinusitis Drugs Market Share by Regions (2015-2020)
Table 14. Global Sinusitis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Sinusitis Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Sinusitis Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Sinusitis Drugs Players
Table 21. Global Sinusitis Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global Sinusitis Drugs Market Share by Players (2015-2020)
Table 23. Global Top Sinusitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sinusitis Drugs as of 2019)
Table 24. Global Sinusitis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Sinusitis Drugs Product Solution and Service
Table 27. Date of Enter into Sinusitis Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global Sinusitis Drugs Market Size Share by Type (2015-2020)
Table 31. Global Sinusitis Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global Sinusitis Drugs Market Size Share by Application (2015-2020)
Table 33. Global Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global Sinusitis Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players Sinusitis Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Sinusitis Drugs Market Share (2019-2020)
Table 37. North America Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America Sinusitis Drugs Market Share by Type (2015-2020)
Table 39. North America Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America Sinusitis Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players Sinusitis Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Sinusitis Drugs Market Share (2019-2020)
Table 43. Europe Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Sinusitis Drugs Market Share by Type (2015-2020)
Table 45. Europe Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Sinusitis Drugs Market Share by Application (2015-2020)
Table 47. China Key Players Sinusitis Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players Sinusitis Drugs Market Share (2019-2020)
Table 49. China Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China Sinusitis Drugs Market Share by Type (2015-2020)
Table 51. China Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China Sinusitis Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players Sinusitis Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Sinusitis Drugs Market Share (2019-2020)
Table 55. Japan Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Sinusitis Drugs Market Share by Type (2015-2020)
Table 57. Japan Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Sinusitis Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Sinusitis Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Sinusitis Drugs Market Share (2019-2020)
Table 61. Southeast Asia Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Sinusitis Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Sinusitis Drugs Market Share by Application (2015-2020)
Table 65. India Key Players Sinusitis Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players Sinusitis Drugs Market Share (2019-2020)
Table 67. India Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India Sinusitis Drugs Market Share by Type (2015-2020)
Table 69. India Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India Sinusitis Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Sinusitis Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Sinusitis Drugs Market Share (2019-2020)
Table 73. Central & South America Sinusitis Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Sinusitis Drugs Market Share by Type (2015-2020)
Table 75. Central & South America Sinusitis Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Sinusitis Drugs Market Share by Application (2015-2020)
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Product
Table 80. Sanofi Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 81. Sanofi Recent Development
Table 82. Bayer Company Details
Table 83. Bayer Business Overview
Table 84. Bayer Product
Table 85. Bayer Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 86. Bayer Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Product
Table 95. AstraZeneca Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 96. AstraZeneca Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Johnson & Johnson Company Details
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Product
Table 105. Johnson & Johnson Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 106. Johnson & Johnson Recent Development
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Product
Table 110. Merck Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 111. Merck Recent Development
Table 112. Amgen Business Overview
Table 113. Amgen Product
Table 114. Amgen Company Details
Table 115. Amgen Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 116. Amgen Recent Development
Table 117. Teva Pharmaceutical Company Details
Table 118. Teva Pharmaceutical Business Overview
Table 119. Teva Pharmaceutical Product
Table 120. Teva Pharmaceutical Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 121. Teva Pharmaceutical Recent Development
Table 122. Fresenius Kabi Company Details
Table 123. Fresenius Kabi Business Overview
Table 124. Fresenius Kabi Product
Table 125. Fresenius Kabi Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 126. Fresenius Kabi Recent Development
Table 127. Bionorica Company Details
Table 128. Bionorica Business Overview
Table 129. Bionorica Product
Table 130. Bionorica Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 131. Bionorica Recent Development
Table 132. Dr. Reddy's Laboratories Company Details
Table 133. Dr. Reddy's Laboratories Business Overview
Table 134. Dr. Reddy's Laboratories Product
Table 135. Dr. Reddy's Laboratories Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 136. Dr. Reddy's Laboratories Recent Development
Table 137. Sun Pharmaceutical Company Details
Table 138. Sun Pharmaceutical Business Overview
Table 139. Sun Pharmaceutical Product
Table 140. Sun Pharmaceutical Revenue in Sinusitis Drugs Business (2015-2020) (Million US$)
Table 141. Sun Pharmaceutical Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sinusitis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Analgesics Features
Figure 3. Antihistamines Features
Figure 4. Corticosteroids Features
Figure 5. Antibiotics Features
Figure 6. Sulphonamides Features
Figure 7. Global Sinusitis Drugs Market Share by Application: 2020 VS 2026
Figure 8. Acute Sinusitis Case Studies
Figure 9. Chronic Sinusitis Case Studies
Figure 10. Sinusitis Drugs Report Years Considered
Figure 11. Global Sinusitis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Sinusitis Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Sinusitis Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Sinusitis Drugs Market Share by Players in 2019
Figure 16. Global Top Sinusitis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sinusitis Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Sinusitis Drugs Revenue in 2019
Figure 18. North America Sinusitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Sinusitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Sinusitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Sinusitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Sinusitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Sinusitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Sinusitis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
急性反復発作薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Repetitive Seizures Drugs Market The global Acute Repetitive Seizures Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Acute Repetitive Seizures Drugs Scope and Market Si…- 抗生物質の世界市場（～2026年） An antibiotic is a type of antimicrobial substance active against bacteria and is the most important type of antibacterial agent for fighting bacterial infections. Increasing bacterial infection coupled with increasing investment and R&D activities in the field for antibiotics drugs are some of the …
- 慢性特発性便秘（CIC）治療薬の世界市場（～2026年） Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of diffi…
- 結膜炎治療薬の世界市場（～2026年） Conjunctivitis, or pink eye, is inflammation of the outermost layer of the white part of the eye and the inner surface of the eyelid due to numerous causes the most common being bacterial infection. The condition is self-limiting, but in some cases results in kerato-conjunctivitis, which results in …
- 家畜用医薬品の世界市場（～2026年） Market Analysis and Insights: Global Farm Animal Drugs Market The global Farm Animal Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Farm Animal Drugs Scope and Market Size Farm Animal Drugs market is segmented b…